What does PHARMACIE H. DOCK do?

PHARMACIE H. DOCK is a logistics company in Faimes. Private Limited, started on 19 June 2002, 1 establishment.

What is the address of PHARMACIE H. DOCK?

The registered office of PHARMACIE H. DOCK is located at Rue de la Champignotte(AIN) 13, 4317 Faimes.

Is PHARMACIE H. DOCK still active?

Yes. According to the CBE (29 October 2026) PHARMACIE H. DOCK is active, legal situation “Normale toestand”, started on 19 June 2002.

Is PHARMACIE H. DOCK registered on Peppol?

Yes, PHARMACIE H. DOCK is registered on the Peppol network with ID 0208:0477766471.

What is the enterprise number of PHARMACIE H. DOCK?

The enterprise number of PHARMACIE H. DOCK is BE0477766471.

When was PHARMACIE H. DOCK founded?

PHARMACIE H. DOCK was founded on 19 June 2002.

Who are the directors of PHARMACIE H. DOCK?

According to the 2025 annual accounts, the directors of PHARMACIE H. DOCK are: DIAGINVEST SRL.

Is PHARMACIE H. DOCK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 June 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE H. DOCK make in 2025?

PHARMACIE H. DOCK posted a profit after taxes of € 9,882 in financial year 2025.

What is the revenue of PHARMACIE H. DOCK?

As a small company, PHARMACIE H. DOCK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 299,419.

How much does an employee at PHARMACIE H. DOCK earn?

The average wage cost per full-time employee at PHARMACIE H. DOCK was € 57,800 in 2025: staff costs of € 213,807 for 3.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE H. DOCK have?

According to the 2025 annual accounts, PHARMACIE H. DOCK has 3.7 full-time equivalents (FTE).

PHARMACIE H. DOCK (Private Limited) - Faimes

Dossier PHARMACIE H. DOCK, printed on 29 October 2026 from databakkes.be/en/0477766471/pharmacie-h-dock. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

16 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

PHARMACIE H. DOCK from Faimes, company number BE0477766471, closed financial year 2025 with a result of € 9,882 after tax. For that financial year PHARMACIE H. DOCK recorded a gross margin of € 299,419 and equity of € 747,144. Compared with financial year 2024, the result moved from € 30,340 to € 9,882. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Growing

€ 747,144

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 9,882

▼ 67% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 70,846

▼ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 722,144.

People and assets in 2025

Full-time equivalents

3.7

▲ 1.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 213,807

▲ 64% vs 2024

€ 57,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 194,338

▼ 12% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 410,074

▼ 10% vs 2024

€ 45,609 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 148,226

▲ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,205

▲ 39% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 181,523 Gross margin 2022: € 181,523 First fiscal year in the series	€ 177,866 Gross margin 2023: € 177,866 ▼ 2% vs 2022 (€ 181,523) Unfavourable step	€ 216,490 Gross margin 2024: € 216,490 ▲ 22% vs 2023 (€ 177,866) Favourable step	€ 299,419 Gross margin 2025: € 299,419 ▲ 38% vs 2024 (€ 216,490) Favourable step	▲ 38%
Profit after taxes	€ 99,254 Profit after taxes 2022: € 99,254 First fiscal year in the series	€ 96,012 Profit after taxes 2023: € 96,012 ▼ 3% vs 2022 (€ 99,254) Unfavourable step	€ 30,340 Profit after taxes 2024: € 30,340 ▼ 68% vs 2023 (€ 96,012) Unfavourable step	€ 9,882 Profit after taxes 2025: € 9,882 ▼ 67% vs 2024 (€ 30,340) Unfavourable step	▼ 67%
Equity	€ 625,911 Equity 2022: € 625,911 First fiscal year in the series	€ 721,922 Equity 2023: € 721,922 ▲ 15% vs 2022 (€ 625,911) Favourable step	€ 737,262 Equity 2024: € 737,262 ▲ 2% vs 2023 (€ 721,922) Favourable step	€ 747,144 Equity 2025: € 747,144 ▲ 1% vs 2024 (€ 737,262) Favourable step	▲ 1%
Total debts	€ 116,004 Total debts 2022: € 116,004 First fiscal year in the series	€ 525,631 Total debts 2023: € 525,631 ▲ € 409,627 vs 2022 (€ 116,004) Unfavourable step	€ 615,470 Total debts 2024: € 615,470 ▲ 17% vs 2023 (€ 525,631) Unfavourable step	€ 602,697 Total debts 2025: € 602,697 ▼ 2% vs 2024 (€ 615,470) Favourable step	▼ 2%
Cash	€ 374,850 Cash 2022: € 374,850 First fiscal year in the series	€ 686,365 Cash 2023: € 686,365 ▲ 83% vs 2022 (€ 374,850) Favourable step	€ 89,597 Cash 2024: € 89,597 ▼ 87% vs 2023 (€ 686,365) Unfavourable step	€ 70,846 Cash 2025: € 70,846 ▼ 21% vs 2024 (€ 89,597) Unfavourable step	▼ 21%
Land & buildings	€ 128,079 Land & buildings 2022: € 128,079 First fiscal year in the series	-	€ 782,377 Land & buildings 2024: € 782,377 First fiscal year in the series	€ 772,149 Land & buildings 2025: € 772,149 ▼ 1% vs 2024 (€ 782,377) Unchanged	▼ 1%
Retained profit	€ 600,911 Retained profit 2022: € 600,911 First fiscal year in the series	€ 696,922 Retained profit 2023: € 696,922 ▲ 16% vs 2022 (€ 600,911) Favourable step	€ 712,262 Retained profit 2024: € 712,262 ▲ 2% vs 2023 (€ 696,922) Favourable step	€ 722,144 Retained profit 2025: € 722,144 ▲ 1% vs 2024 (€ 712,262) Favourable step	▲ 1%
Dividend	€ 60,000 Dividend 2022: € 60,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 60,000) Unchanged	€ 15,000 Dividend 2024: € 15,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 15,000) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 450,000 Bank debt 2023: € 450,000 Unchanged (€ 0) Unfavourable step	€ 457,673 Bank debt 2024: € 457,673 ▲ 2% vs 2023 (€ 450,000) Unfavourable step	€ 410,074 Bank debt 2025: € 410,074 ▼ 10% vs 2024 (€ 457,673) Favourable step	▼ 10%
Balance sheet total	€ 741,915 Balance sheet total 2022: € 741,915 First fiscal year in the series	€ 1,247,553 Balance sheet total 2023: € 1,247,553 ▲ 68% vs 2022 (€ 741,915) Unchanged	€ 1,352,732 Balance sheet total 2024: € 1,352,732 ▲ 8% vs 2023 (€ 1,247,553) Unchanged	€ 1,349,842 Balance sheet total 2025: € 1,349,842 Unchanged (€ 1,352,732) Unchanged
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	2.1 Employees (FTE) 2024: 2.1 ▲ 1.1 vs 2023 (1) Unchanged	3.7 Employees (FTE) 2025: 3.7 ▲ 1.6 vs 2024 (2.1) Unchanged	▲ 1.6

Key figures of PHARMACIE H. DOCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE H. DOCK?

What happened at PHARMACIE H. DOCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: profit of € 9,882 (▼ 67% vs 2024). Source: NBB ↗
2023 DIAGINVEST SRL became a director. NBB
Sep 25, 2002 New establishment in Héron. KBO
Jun 19, 2002 Start of the company according to the CBE. KBO

In short

From € 99,254 profit in 2022 to € 9,882 profit in 2025.

Paid € 84,756 in corporate taxes since 2022.

Best year ever: 2022, with € 99,254 profit.

On average € 80,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DIAGINVEST 100%

The stake of DIAGINVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE H. DOCK

Behind PHARMACIE H. DOCK is DIAGINVEST SRL. The shares are held by DIAGINVEST (100%).

Directors

According to the 2025 annual accounts

DIAGINVEST SRL

Director · represented by Luc OLIVIER

since 2023

Shareholders

DIAGINVEST

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Champignotte(AIN) 13

4317 Faimes

2.114.978.003

Chaussée de Wavre 33 box a

4217 Héron

Active since 25 September 2002

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.

All companies at this address →

Pharmacie J.P. Detry - Discry

€ 255,389 gross margin · 2025

PHARMACIE DE DONCEEL

€ 175,420 gross margin · 2025

PHARMACIE DUBOIS-HUSSON

€ 475,076 gross margin · 2025

Pharmacie DETRY-DUPONT

€ 297,327 gross margin · 2025

PHARMACIE R. WALNIER

€ 463,240 gross margin · 2025

+11 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0477.766.471

VAT number

BE 0477.766.471

Registered office

Rue de la Champignotte(AIN) 13, 4317 Faimes

Names & denominations

PHARMACIE H. DOCK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 June 2002

Peppol

Active · Active since 11 Sept 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE H. DOCK

Warning lights

Financials

What happened to PHARMACIE H. DOCK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions